These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 5800679)
1. [On the therapy of Sjogren's syndrome using cyclophosphamide]. Messmer E Dtsch Med J; 1969 Jun; 20(11):383-4. PubMed ID: 5800679 [No Abstract] [Full Text] [Related]
2. Acute leukemia following cyclophosphamide therapy for Sjögren's syndrome. Hochberg MC; Shulman LE Johns Hopkins Med J; 1978 Jun; 142(6):211-4. PubMed ID: 275517 [TBL] [Abstract][Full Text] [Related]
3. [The therapy of Sjögren's syndrome]. Schnabel A Dtsch Med Wochenschr; 1995 Jun; 120(22):814-5. PubMed ID: 7781516 [No Abstract] [Full Text] [Related]
4. [Cyclophosphamide treatment of parotid swelling in Sjögren syndrome]. Aliaga L; Quiroga J; Prieto J Med Clin (Barc); 1984 Jun; 83(5):222-3. PubMed ID: 6482585 [No Abstract] [Full Text] [Related]
5. Connective tissue disorders in India II. Clinical and immunological studies in Sjogren's syndrome. Malaviya AN; Kar A; Goswami S; Bhuyan UN; Kumar R; Malhotra KK; Taneja RL J Assoc Physicians India; 1978 Jul; 26(7):553-60. PubMed ID: 721760 [No Abstract] [Full Text] [Related]
6. Cyclophosphamide induced water intoxication in a woman with Sjögren's syndrome. Spital A; Ristow S J Rheumatol; 1997 Dec; 24(12):2473-5. PubMed ID: 9415661 [TBL] [Abstract][Full Text] [Related]
7. [Current viewpoints of Sjögren's syndrome]. De Landsheere D; Van Cauwenberge P Acta Otorhinolaryngol Belg; 1984; 38(2):177-85. PubMed ID: 6435389 [TBL] [Abstract][Full Text] [Related]
8. [Cyclophosphamide-responsive subclinical Sjögren's syndrome in a patient with initial peripheral and central nervous system involvement]. Yamanishi Y; Taooka Y; Mukuzono H; Aoi K; Ishibe Y; Yamana S Ryumachi; 1994 Jun; 34(3):633-8. PubMed ID: 8052929 [TBL] [Abstract][Full Text] [Related]
10. [Combination of rituximab with combined pulse-therapy with high doses of methylprednisolone and cyclophosphamide: effects on immunomorphological and functional disturbances of the salivary glands in a patient with Sjogren's disease and MALT-lymphoma]. Vasil'ev VI; Kokosadze NV; Logvinenko OA; Nikitin EA; Mitrikov BV; Rodionova EB; Varlamova EIu Ter Arkh; 2008; 80(5):76-9. PubMed ID: 18590121 [No Abstract] [Full Text] [Related]